Progesterone receptor modulates ERα action in breast cancer H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ... Nature 523 (7560), 313-317, 2015 | 806 | 2015 |
Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254-268, 2017 | 720 | 2017 |
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution P Eirew, A Steif, J Khattra, G Ha, D Yap, H Farahani, K Gelmon, S Chia, ... Nature 518 (7539), 422-426, 2015 | 679 | 2015 |
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene A Bruna, RS Darken, F Rojo, A Ocaña, S Peñuelas, A Arias, R Paris, ... Cancer cell 11 (2), 147-160, 2007 | 601 | 2007 |
A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ... Cell 167 (1), 260-274. e22, 2016 | 480 | 2016 |
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells H Dev, TWW Chiang, C Lescale, I de Krijger, AG Martin, D Pilger, ... Nature cell biology 20 (8), 954-965, 2018 | 410 | 2018 |
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, ... Annals of Oncology 29 (5), 1203-1210, 2018 | 406 | 2018 |
Maintaining tumor heterogeneity in patient-derived tumor xenografts JW Cassidy, C Caldas, A Bruna Cancer research 75 (15), 2963-2968, 2015 | 370 | 2015 |
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups OM Rueda, SJ Sammut, JA Seoane, SF Chin, JL Caswell-Jin, M Callari, ... Nature 567 (7748), 399-404, 2019 | 351 | 2019 |
A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation M Castroviejo‐Bermejo, C Cruz, A Llop‐Guevara, S Gutiérrez‐Enríquez, ... EMBO molecular medicine 10 (12), e9172, 2018 | 259 | 2018 |
Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing E Laks, A McPherson, H Zahn, D Lai, A Steif, J Brimhall, J Biele, B Wang, ... Cell 179 (5), 1207-1221. e22, 2019 | 231 | 2019 |
Glucocorticoid receptor–JNK interaction mediates inhibition of the JNK pathway by glucocorticoids A Bruna, M Nicolàs, A Muñoz, JM Kyriakis, C Caelles The EMBO journal 22 (22), 6035-6044, 2003 | 170 | 2003 |
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response S Nagarajan, SV Rao, J Sutton, D Cheeseman, S Dunn, EK Papachristou, ... Nature genetics 52 (2), 187-197, 2020 | 158 | 2020 |
Landscape of G-quadruplex DNA structural regions in breast cancer R Hänsel-Hertsch, A Simeone, A Shea, WWI Hui, KG Zyner, G Marsico, ... Nature genetics 52 (9), 878-883, 2020 | 154 | 2020 |
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ... EMBO molecular medicine 3 (3), 167-180, 2011 | 144 | 2011 |
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer A Bruna, W Greenwood, J Le Quesne, A Teschendorff, ... Nature communications 3 (1), 1055, 2012 | 134 | 2012 |
PDX-MI: minimal information for patient-derived tumor xenograft models TF Meehan, N Conte, T Goldstein, G Inghirami, MA Murakami, S Brabetz, ... Cancer research 77 (21), e62-e66, 2017 | 130 | 2017 |
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models Z Xue, DJ Vis, A Bruna, T Sustic, S van Wageningen, AS Batra, ... Cell research 28 (7), 719-729, 2018 | 117 | 2018 |
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity EMC Tacconi, X Lai, C Folio, M Porru, G Zonderland, S Badie, J Michl, ... EMBO Molecular Medicine 9 (10), 1398-1414, 2017 | 75 | 2017 |
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis D Avanzato, E Pupo, N Ducano, C Isella, G Bertalot, C Luise, S Pece, ... Cancer research 78 (13), 3432-3444, 2018 | 73 | 2018 |